SPONSOR
Al-Mustansiriyah University
Total Trials
2
Recruiting
2
Phases
Phase 3, Phase 4
Conditions studied: HalitosisMouth DiseasePlaque Induced Gingival DiseaseBleeding GumPeridontal DiseaseITP - Immune Thrombocytopenia
Al-Mustansiriyah University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Halitosis, Mouth Disease, Plaque Induced Gingival Disease, Bleeding Gum.
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Al-Mustansiriyah University
How many clinical trials has Al-Mustansiriyah University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Al-Mustansiriyah University, of which 2 are actively recruiting participants. These trials cover conditions including Halitosis, Mouth Disease, Plaque Induced Gingival Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Al-Mustansiriyah University research focus on?
Al-Mustansiriyah University clinical trials span Halitosis, Mouth Disease, Plaque Induced Gingival Disease, Bleeding Gum, Peridontal Disease, and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Al-Mustansiriyah University clinical trial?
To participate in a Al-Mustansiriyah University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Al-Mustansiriyah University trials with current recruitment status updated daily.
Clinical Trials by Al-Mustansiriyah University
NCT06882564 Phase 3
Recruiting
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
Halitosis
NCT07133659 Phase 4
Recruiting
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
ITP - Immune Thrombocytopenia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology